{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T11:11:57Z","timestamp":1789125117850,"version":"build-2803163510"},"reference-count":119,"publisher":"Bioscientifica","issue":"5","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,1]]},"abstract":"<jats:p>Polycystic ovary syndrome (PCOS) is a multifaceted endocrine\u2013metabolic disorder in which androgenetic alopecia (AGA) serves as a prominent clinical marker of profound systemic dysregulation, extending beyond simple hyperandrogenism. This condition imposes a significant psychosocial burden on affected women, yet its complete pathophysiology remains incompletely understood, leading to therapeutic plateaus. This review advances the central hypothesis that alopecia in PCOS results from a synergistic failure of local follicular metabolic signaling and genetic predisposition. This framework posits that the hair follicle in susceptible individuals is a site of intrinsic vulnerability where systemic insults, principally insulin resistance and chronic low-grade inflammation, converge with specific gene polymorphisms. This local pathology both amplifies and is amplified by systemic hyperandrogenism, rendering androgen action a necessary but insufficient component of the complete pathophysiological cascade. This integrated perspective recontextualizes the roles of insulin, inflammatory mediators, and genetic variants as direct effectors of follicular distress, not merely as upstream triggers of androgen excess. We critically synthesize the evidence supporting this model, examining the intricate intersections of systemic hormone bioavailability, local androgen conversion, follicular bioenergetics, and genetic susceptibility. Furthermore, we provide an evidence-based, mechanistically organized framework for the management of PCOS-associated alopecia, evaluating therapeutic modalities based on their targeted action within this complex network. A deeper, systems-level understanding of this interplay is essential for moving beyond current therapeutic limitations and developing personalized management strategies that address the complete pathophysiological axis, ultimately improving both cutaneous and long-term systemic health outcomes for women with PCOS.<\/jats:p>","DOI":"10.1530\/ec-25-0728","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T17:25:44Z","timestamp":1778174744000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-10","source":"Crossref","is-referenced-by-count":1,"title":["Androgenetic alopecia in polycystic ovary syndrome: a cutaneous marker of systemic metabo-inflammatory and endocrine dysfunction"],"prefix":"10.1530","volume":"15","author":[{"given":"Farzaneh","family":"Motafeghi","sequence":"first","affiliation":[{"name":"Reproductive Endocrinology Research Center, Research Institute for Endocrine Molecular Biology, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzieh","family":"Saei Ghare Naz","sequence":"additional","affiliation":[{"name":"Reproductive Endocrinology Research Center, Research Institute for Endocrine Molecular Biology, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahimeh","family":"Ramezani Tehrani","sequence":"additional","affiliation":[{"name":"Reproductive Endocrinology Research Center, Research Institute for Endocrine Molecular Biology, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran 1"},{"name":"Foundation for Research & Education Excellence, Vestavia Hills, Alabama, USA 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3526-640X","authenticated-orcid":true,"given":"Samira","family":"Behboudi-Gandevani","sequence":"additional","affiliation":[{"name":"Faculty of Nursing and Health Sciences, NORD University, Bod\u00f8, Norway 3"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"key":"2026091106564491600_bib1","doi-asserted-by":"crossref","DOI":"10.1530\/EC-23-0179","article-title":"Improving emotional and psychosexual well-being screening in women living with polycystic ovary syndrome: experiences from the United Kingdom and India","volume":"12","author":"Hebbar","year":"2023","journal-title":"Endocr Connect"},{"key":"2026091106564491600_bib2","doi-asserted-by":"crossref","DOI":"10.1530\/EC-25-0266","article-title":"Longitudinal trajectories of insulin resistance in women with polycystic ovary syndrome: a functional data analysis approach","volume":"14","author":"Ramezani Tehrani","year":"2025","journal-title":"Endocr Connect"},{"key":"2026091106564491600_bib3","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3109\/09513590.2015.1117069","article-title":"Insulin resistance in obesity and polycystic ovary syndrome: systematic review and meta-analysis of observational studies","volume":"32","author":"Behboudi-Gandevani","year":"2016","journal-title":"Gynecol Endocrinol"},{"key":"2026091106564491600_bib4","doi-asserted-by":"crossref","first-page":"E85","DOI":"10.1503\/cmaj.231251","article-title":"Diagnosis and management of polycystic ovarian syndrome","volume":"196","author":"Dason","year":"2024","journal-title":"CMAJ"},{"key":"2026091106564491600_bib5","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.fertnstert.2014.01.003","article-title":"Prevalence of androgenic alopecia in patients with polycystic ovary syndrome and characterization of associated clinical and biochemical features","volume":"101","author":"Quinn","year":"2014","journal-title":"Fertil Steril"},{"key":"2026091106564491600_bib6","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.3390\/jcm12041454","article-title":"Polycystic ovary syndrome: etiology, current management, and future therapeutics","volume":"12","author":"Singh","year":"2023","journal-title":"J Clin Med"},{"key":"2026091106564491600_bib7","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1210\/jc.2018-02548","article-title":"Female pattern hair loss and androgen excess: a report from the multidisciplinary androgen excess and PCOS committee","volume":"104","author":"Carmina","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"2026091106564491600_bib8","doi-asserted-by":"crossref","first-page":"7770","DOI":"10.12659\/MSM.913116","article-title":"Serum levels of androgen-associated hormones are correlated with curative effect in androgenic alopecia in young men","volume":"24","author":"Zhang","year":"2018","journal-title":"Med Sci Monit"},{"key":"2026091106564491600_bib9","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13059","article-title":"Physiopathology and current treatments of androgenetic alopecia: going beyond androgens and anti-androgens","volume":"32","author":"Katzer","year":"2019","journal-title":"Dermatol Ther"},{"key":"2026091106564491600_bib10","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/1523-1747.ep12335779","article-title":"Different levels of 5\u03b1-Reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia","volume":"109","author":"Sawaya","year":"1997","journal-title":"J Invest Dermatol"},{"key":"2026091106564491600_bib11","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jaad.2020.01.075","article-title":"Polycystic ovary syndrome in patients with hair thinning","volume":"83","author":"Prasad","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"2026091106564491600_bib12","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1751-7125.2008.07586.x","article-title":"Diagnosis and management of primary cicatricial alopecia: part II","volume":"7","author":"Wu","year":"2008","journal-title":"Skinmed"},{"key":"2026091106564491600_bib13","first-page":"371","article-title":"Hair loss: common causes and treatment","volume":"96","author":"Phillips","year":"2017","journal-title":"Am Fam Physician"},{"key":"2026091106564491600_bib14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s12020-017-1280-y","article-title":"Androgenetic alopecia: a review","volume":"57","author":"Lolli","year":"2017","journal-title":"Endocrine"},{"key":"2026091106564491600_bib15","doi-asserted-by":"crossref","first-page":"26","DOI":"10.17925\/USE.2016.12.01.26","article-title":"Predictors of scalp hair thinning in women with polycystic ovary syndrome","volume":"12","author":"Ikhena","year":"2016","journal-title":"US Endocrinol"},{"key":"2026091106564491600_bib16","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/17446651.2019.1576522","article-title":"Hyperandrogenic origins of polycystic ovary syndrome - implications for pathophysiology and therapy","volume":"14","author":"Abbott","year":"2019","journal-title":"Expert Rev Endocrinol Metab"},{"key":"2026091106564491600_bib17","first-page":"We01","article-title":"Telogen effluvium: a review","volume":"9","author":"Malkud","year":"2015","journal-title":"J Clin Diagn Res"},{"key":"2026091106564491600_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/abp.2025.14241","article-title":"Effects of postpartum hormonal changes on the immune system and their role in recovery","volume":"72","author":"Wu","year":"2025","journal-title":"Acta Biochim Pol"},{"key":"2026091106564491600_bib19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.21103\/Article13(1)_RA4","article-title":"Telogen effluvium, diagnosis and management: a narrative review","volume":"13","author":"Hussein","year":"2023","journal-title":"Int J Biomed"},{"key":"2026091106564491600_bib20","first-page":"1235","article-title":"Vitamin and mineral deficiencies in patients with telogen effluvium: a retrospective cross-sectional study","volume":"15","author":"Cheung","year":"2016","journal-title":"J Drugs Dermatol"},{"key":"2026091106564491600_bib21","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1046\/j.1523-1747.2003.12168.x","article-title":"Androgenetic alopecia in women","volume":"8","author":"Price","year":"2003","journal-title":"J Invest Dermatol Symp Proc"},{"key":"2026091106564491600_bib22","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1038\/jidsymp.2013.7","article-title":"The role of hair follicle immune privilege collapse in alopecia areata: status and perspectives","volume":"16","author":"Paus","year":"2013","journal-title":"J Invest Dermatol Symp Proc"},{"key":"2026091106564491600_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.11","article-title":"Alopecia areata","volume":"3","author":"Pratt","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"2026091106564491600_bib24","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/biolre\/ioab050","article-title":"Inflammation and reproductive function in women with polycystic ovary syndrome","volume":"104","author":"Velez","year":"2021","journal-title":"Biol Reprod"},{"key":"2026091106564491600_bib25","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/1346-8138.15659","article-title":"Increased risk of alopecia areata among patients with polycystic ovary syndrome: A population-based cohort study","volume":"48","author":"Chang","year":"2021","journal-title":"J Dermatol"},{"key":"2026091106564491600_bib26","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.3390\/diagnostics12081922","article-title":"Hirsutism, normal androgens and diagnosis of PCOS","volume":"12","author":"Spritzer","year":"2022","journal-title":"Diagnostics"},{"key":"2026091106564491600_bib27","doi-asserted-by":"crossref","first-page":"5342","DOI":"10.3390\/ijms21155342","article-title":"Hormonal effects on hair follicles","volume":"21","author":"Grymowicz","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2026091106564491600_bib28","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/j.jid.2022.01.003","article-title":"Androgen receptor-mediated paracrine signaling induces regression of blood vessels in the dermal papilla in androgenetic alopecia","volume":"142","author":"Deng","year":"2022","journal-title":"J Invest Dermatol"},{"key":"2026091106564491600_bib29","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1038\/s41598-022-05544-w","article-title":"Weekly treatment with SAMiRNA targeting the androgen receptor ameliorates androgenetic alopecia","volume":"12","author":"Yun","year":"2022","journal-title":"Sci Rep"},{"key":"2026091106564491600_bib30","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/1523-1747.ep12874003","article-title":"5\u03b1-Reductase activity in cultured human dermal papilla cells from beard compared with reticular dermal fibroblasts","volume":"94","author":"Itami","year":"1990","journal-title":"J Invest Dermatol"},{"key":"2026091106564491600_bib31","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/1523-1747.ep12335779","article-title":"Different levels of 5\u03b1-reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia","volume":"109","author":"Sawaya","year":"1997","journal-title":"J Invest Dermatol"},{"key":"2026091106564491600_bib32","doi-asserted-by":"crossref","first-page":"8711","DOI":"10.1074\/jbc.H119.009180","article-title":"Keys to unlock androgen receptor translocation","volume":"294","author":"Tien","year":"2019","journal-title":"J Biol Chem"},{"key":"2026091106564491600_bib33","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/exd.12024","article-title":"Androgen actions on the human hair follicle: perspectives","volume":"22","author":"Inui","year":"2013","journal-title":"Exp Dermatol"},{"key":"2026091106564491600_bib34","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/s13287-025-04420-4","article-title":"Pathophysiological mechanisms of hair follicle regeneration and potential therapeutic strategies","volume":"16","author":"Bellani","year":"2025","journal-title":"Stem Cell Res Ther"},{"key":"2026091106564491600_bib35","doi-asserted-by":"crossref","first-page":"7349","DOI":"10.2147\/DDDT.S542000","article-title":"Androgenetic alopecia: an update on pathogenesis and pharmacological treatment","volume":"19","author":"Chen","year":"2025","journal-title":"Drug Des Devel Ther"},{"key":"2026091106564491600_bib36","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s12967-023-04116-4","article-title":"The interplay between androgens and the immune response in polycystic ovary syndrome","volume":"21","author":"Shabbir","year":"2023","journal-title":"J Transl Med"},{"key":"2026091106564491600_bib37","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.jfma.2019.04.013","article-title":"HSD3B1 gene polymorphism and female pattern hair loss in women with polycystic ovary syndrome","volume":"118","author":"Tu","year":"2019","journal-title":"J Formos Med Assoc"},{"key":"2026091106564491600_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-02581-z","article-title":"Oxyresveratrol enhances hair regeneration in human dermal papilla cell and androgenetic alopecia mouse model","volume":"15","author":"Tran","year":"2025","journal-title":"Sci Rep"},{"key":"2026091106564491600_bib39","doi-asserted-by":"crossref","first-page":"93","DOI":"10.5468\/ogs.24255","article-title":"The impact of GABA and GABAergic pathway in polycystic ovary syndrome: a systematic review","volume":"68","author":"Motafeghi","year":"2025","journal-title":"Obstet Gynecol Sci"},{"key":"2026091106564491600_bib40","article-title":"GABA dysfunction and its consequences in women with polycystic ovary syndrome","volume":"27","author":"Motafeghi","year":"2025","journal-title":"J Babol Univ Med Sci"},{"key":"2026091106564491600_bib41","first-page":"20","article-title":"Anthropometric, hormonal and biochemical indices in patients with polycystic ovarian syndrome","volume":"3","author":"Mutib","year":"2013","journal-title":"IJEIR"},{"key":"2026091106564491600_bib42","doi-asserted-by":"crossref","first-page":"8191","DOI":"10.3390\/ijms21218191","article-title":"Sex hormone-binding globulin (SHBG) as an early biomarker and therapeutic target in polycystic ovary syndrome","volume":"21","author":"Qu","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2026091106564491600_bib43","doi-asserted-by":"crossref","first-page":"E732","DOI":"10.1152\/ajpendo.90477.2008","article-title":"Impaired microvascular perfusion: a consequence of vascular dysfunction and a potential cause of insulin resistance in muscle","volume":"295","author":"Clark","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2026091106564491600_bib44","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.2337\/diabetes.51.5.1515","article-title":"Direct evidence for insulin-induced capillary recruitment in skin of healthy subjects during physiological hyperinsulinemia","volume":"51","author":"Sern\u00e9","year":"2002","journal-title":"Diabetes"},{"key":"2026091106564491600_bib45","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.2337\/diabetes.50.7.1627","article-title":"Glucose effects on skin keratinocytes: implications for diabetes skin complications","volume":"50","author":"Spravchikov","year":"2001","journal-title":"Diabetes"},{"key":"2026091106564491600_bib46","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/978-3-030-76111-0_16","volume-title":"Androgenetic Alopecia From A to Z","author":"Anastassakis","year":"2022"},{"key":"2026091106564491600_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1191759","article-title":"Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome","volume":"14","author":"Wang","year":"2023","journal-title":"Front Endocrinol"},{"key":"2026091106564491600_bib48","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-92265-1","article-title":"Impact of rs2414096 polymorphism of CYP19 gene on susceptibility of polycystic ovary syndrome and hyperandrogenism in Kashmiri women","volume":"11","author":"Ashraf","year":"2021","journal-title":"Sci Rep"},{"key":"2026091106564491600_bib49","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.3390\/genes14071326","article-title":"Female pattern hair loss: an overview with focus on the genetics","volume":"14","author":"Ho","year":"2023","journal-title":"Genes"},{"key":"2026091106564491600_bib50","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2133.2009.09186.x","article-title":"Gene-wide association study between the aromatase gene (CYP19A1) and female pattern hair loss","volume":"161","author":"Yip","year":"2009","journal-title":"Br J Dermatol"},{"key":"2026091106564491600_bib51","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1080\/09513590.2020.1770724","article-title":"CYP17 gene polymorphic sequence variation is associated with hyperandrogenism in Kashmiri women with polycystic ovarian syndrome","volume":"37","author":"Ashraf","year":"2021","journal-title":"Gynecol Endocrinol"},{"key":"2026091106564491600_bib52","doi-asserted-by":"crossref","first-page":"626","DOI":"10.4103\/0378-6323.116732","article-title":"Female pattern hair loss","volume":"79","author":"Singal","year":"2013","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"2026091106564491600_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2025.05.824","article-title":"63835 exploring the link between metabolic syndrome and female pattern hair loss: a systematic review","volume":"93","author":"Hern\u00e1ndez-Coronado","year":"2025","journal-title":"J Am Acad Dermatol"},{"key":"2026091106564491600_bib54","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqaf166","article-title":"Unpacking PCOS inflammation: from misconceptions to immune networks","volume":"166","author":"De Robles","year":"2025","journal-title":"Endocrinology"},{"key":"2026091106564491600_bib55","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.mehy.2016.08.009","article-title":"Hair follicle characteristics as early marker of type 2 diabetes","volume":"95","author":"Miranda","year":"2016","journal-title":"Med Hypotheses"},{"key":"2026091106564491600_bib56","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jsbmb.2009.12.010","article-title":"Insulin and hyperandrogenism in women with polycystic ovary syndrome","volume":"122","author":"Baptiste","year":"2010","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2026091106564491600_bib57","doi-asserted-by":"crossref","first-page":"8191","DOI":"10.3390\/ijms21218191","article-title":"Sex hormone-binding globulin (SHBG) as an early biomarker and therapeutic target in polycystic ovary syndrome","volume":"21","author":"Qu","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2026091106564491600_bib58","doi-asserted-by":"crossref","DOI":"10.1111\/jocd.70458","article-title":"Increased prevalence of insulin resistance and metabolic syndrome in men with early-onset androgenetic alopecia: a case-control study","volume":"24","author":"Erden","year":"2025","journal-title":"J Cosmet Dermatol"},{"key":"2026091106564491600_bib59","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2147\/CCID.S492958","article-title":"Exploring the causal relationship and molecular mechanisms between fasting insulin and androgenetic alopecia: a mendelian randomization study with bioinformatics analysis","volume":"18","author":"Ding","year":"2025","journal-title":"Clin Cosmet Invest Dermatol"},{"key":"2026091106564491600_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2007.09.014","article-title":"How should we manage atherogenic dyslipidemia in women with polycystic ovary syndrome?","volume":"198","author":"Rizzo","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"2026091106564491600_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111099","article-title":"Ceramides and mitochondrial homeostasis","volume":"117","author":"Ding","year":"2024","journal-title":"Cell Signal"},{"key":"2026091106564491600_bib62","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41420-023-01379-0","article-title":"Lysosomal Ca2+ as a mediator of palmitate-induced lipotoxicity","volume":"9","author":"Oh","year":"2023","journal-title":"Cell Death Discov"},{"key":"2026091106564491600_bib63","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/j.jid.2018.01.033","article-title":"Peroxisome proliferator\u2013activated Receptor-\u03b3\u2212Mediated signaling regulates mitochondrial energy metabolism in human hair follicle epithelium","volume":"138","author":"Ramot","year":"2018","journal-title":"J Invest Dermatol"},{"key":"2026091106564491600_bib64","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/exd.14062","article-title":"PPAR-\u03b3 signalling as a key mediator of human hair follicle physiology and pathology","volume":"29","author":"Ramot","year":"2020","journal-title":"Exp Dermatol"},{"key":"2026091106564491600_bib65","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.stem.2013.10.003","article-title":"Distinct functions for Wnt\/\u03b2-catenin in hair follicle stem cell proliferation and survival and interfollicular epidermal homeostasis","volume":"13","author":"Choi","year":"2013","journal-title":"Cell Stem Cell"},{"key":"2026091106564491600_bib66","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1152\/physiol.00037.2018","article-title":"Impact of lipotoxicity on tissue \u2018Cross Talk\u2019 and metabolic regulation","volume":"34","author":"Montgomery","year":"2019","journal-title":"Physiology"},{"key":"2026091106564491600_bib67","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.18486","article-title":"Oxidative stress in hair follicle development and hair growth: signalling pathways, intervening mechanisms and potential of natural antioxidants","volume":"28","author":"Du","year":"2024","journal-title":"J Cell Mol Med"},{"key":"2026091106564491600_bib68","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1210\/clinem\/dgad356","article-title":"Adipose tissue dysfunction in polycystic ovary syndrome","volume":"109","author":"Bril","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"2026091106564491600_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1470283","article-title":"Systematic low-grade chronic inflammation and intrinsic mechanisms in polycystic ovary syndrome","volume":"15","author":"Deng","year":"2024","journal-title":"Front Immunol"},{"key":"2026091106564491600_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1475465","article-title":"Adipokines as biochemical marker of polycystic ovary syndrome in adolescents \u2013 review","volume":"16","author":"Orszulak","year":"2025","journal-title":"Front Endocrinol"},{"key":"2026091106564491600_bib71","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s12015-025-11050-z","article-title":"Reactive oxygen species and hair follicle stem cell dysfunction","volume":"22","author":"Shome","year":"2026","journal-title":"Stem Cell Rev Rep"},{"key":"2026091106564491600_bib72","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3390\/biom14010020","article-title":"Controlling hair loss by regulating apoptosis in hair follicles: a comprehensive overview","volume":"14","author":"Wang","year":"2023","journal-title":"Biomolecules"},{"key":"2026091106564491600_bib73","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1731179","article-title":"Adipose-androgen crosstalk in polycystic ovary syndrome: mechanisms and therapeutic implications","volume":"16","author":"Ni","year":"2025","journal-title":"Front Endocrinol"},{"key":"2026091106564491600_bib74","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26209926","article-title":"Molecular impact of metabolic and endocrine disturbance on endometrial function in polycystic ovary syndrome","volume":"26","author":"Parker","year":"2025","journal-title":"Int J Mol Sci"},{"key":"2026091106564491600_bib75","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jid.2016.08.035","article-title":"Oxidative damage control in a human (Mini-) organ: Nrf2 activation protects against oxidative stress-induced hair growth inhibition","volume":"137","author":"Haslam","year":"2017","journal-title":"J Invest Dermatol"},{"key":"2026091106564491600_bib76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5021\/ad.24.047","article-title":"Protective effects of Korean red ginseng against oxidative stress-induced damage in human hair","volume":"37","author":"Jung","year":"2025","journal-title":"Ann Dermatol"},{"key":"2026091106564491600_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2121-10-1","article-title":"Cell and molecular mechanisms of keratinocyte function stimulated by insulin during wound healing","volume":"10","author":"Liu","year":"2009","journal-title":"BMC Cell Biol"},{"key":"2026091106564491600_bib78","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000035242","article-title":"Identification of immune microenvironment changes, immune-related pathways and genes in male androgenetic alopecia","volume":"102","author":"Xiong","year":"2023","journal-title":"Medicine"},{"key":"2026091106564491600_bib79","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/jid.2008.369","article-title":"Hair follicle stem cell-specific PPARgamma deletion causes scarring alopecia","volume":"129","author":"Karnik","year":"2009","journal-title":"J Invest Dermatol"},{"key":"2026091106564491600_bib80","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.3390\/diagnostics14222578","article-title":"Deciphering the role of androgen in the dermatologic manifestations of polycystic ovary syndrome patients: a state-of-the-art review","volume":"14","author":"Taieb","year":"2024","journal-title":"Diagnostics"},{"key":"2026091106564491600_bib81","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4103\/0974-7753.96082","article-title":"Female pattern hair loss: clinico-laboratory findings and trichoscopy depending on disease severity","volume":"4","author":"Zhang","year":"2012","journal-title":"Int J Trichol"},{"key":"2026091106564491600_bib82","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.2147\/CCID.S422335","article-title":"Differences in demographic and clinical characteristics among subtypes of female pattern hair loss","volume":"16","author":"Sakpuwadol","year":"2023","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"2026091106564491600_bib83","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.40583","article-title":"Prevalence, phenotypes, and comorbidities of polycystic ovary syndrome among Indian women","volume":"7","author":"Ganie","year":"2024","journal-title":"JAMA Netw Open"},{"key":"2026091106564491600_bib84","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1210\/en.2019-00588","article-title":"Inflammatory stimuli trigger increased androgen production and shifts in gene expression in theca-interstitial cells","volume":"160","author":"Fox","year":"2019","journal-title":"Endocrinology"},{"key":"2026091106564491600_bib85","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s40257-013-0010-3","article-title":"Health status, coping strategies, and alexithymia in subjects with androgenetic alopecia: a questionnaire study","volume":"14","author":"Tabolli","year":"2013","journal-title":"Am J Clin Dermatol"},{"key":"2026091106564491600_bib86","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1111\/jocd.14537","article-title":"Treatment options for androgenetic alopecia: efficacy, side effects, compliance, financial considerations, and ethics","volume":"20","author":"Nestor","year":"2021","journal-title":"J Cosmet Dermatol"},{"key":"2026091106564491600_bib87","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1093\/bjd\/ljaf189","article-title":"Psychosocial burden and the impact of illness perceptions and stigma on quality of life, anxiety and depression in alopecia areata: results from the alopecia + me study","volume":"193","author":"Christou","year":"2025","journal-title":"Br J Dermatol"},{"key":"2026091106564491600_bib88","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/jocd.14983","article-title":"The psychological consequences of androgenetic alopecia: a systematic review","volume":"22","author":"Aukerman","year":"2023","journal-title":"J Cosmet Dermatol"},{"key":"2026091106564491600_bib89","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1210\/clinem\/dgad463","article-title":"Recommendations from the 2023 International evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"108","author":"Teede","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"2026091106564491600_bib90","volume-title":"International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome 2023","author":"Teede","year":"2023"},{"key":"2026091106564491600_bib91","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.abd.2022.09.006","article-title":"Female-pattern hair loss: therapeutic update","volume":"98","author":"M\u00fcller Ramos","year":"2023","journal-title":"An Bras Dermatol"},{"key":"2026091106564491600_bib92","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1046\/j.1365-2133.2002.04798.x","article-title":"Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial","volume":"146","author":"Vexiau","year":"2002","journal-title":"Br J Dermatol"},{"key":"2026091106564491600_bib93","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jaad.2022.01.017","article-title":"Randomized clinical trial of low-dose oral minoxidil for the treatment of female pattern hair loss: 0.25 mg versus 1 mg","volume":"87","author":"Silva","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"2026091106564491600_bib94","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jaad.2015.06.063","article-title":"Demographics of women with female pattern hair loss and the effectiveness of spironolactone therapy","volume":"73","author":"Shannon","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"2026091106564491600_bib95","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1365-2133.2005.06218.x","article-title":"Treatment of female pattern hair loss with oral antiandrogens","volume":"152","author":"Sinclair","year":"2005","journal-title":"Br J Dermatol"},{"key":"2026091106564491600_bib96","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s13555-024-01324-8","article-title":"Hormonal therapies for acne: a comprehensive update for dermatologists","volume":"15","author":"Smith","year":"2025","journal-title":"Dermatol Ther"},{"key":"2026091106564491600_bib97","volume-title":"Aldactone (Spironolactone) Prescribing Information","author":"Administration USFaD","year":"2018"},{"key":"2026091106564491600_bib98","doi-asserted-by":"crossref","first-page":"521","DOI":"10.4103\/0378-6323.144162","article-title":"The effectiveness of finasteride and dutasteride used for 3 years in women with androgenetic alopecia","volume":"80","author":"Verdonschot","year":"2014","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"2026091106564491600_bib99","first-page":"833","article-title":"Dutasteride for the treatment of androgenetic alopecia: an updated review","volume":"240","author":"Ding","year":"2024","journal-title":"Dermatology"},{"key":"2026091106564491600_bib100","first-page":"226","article-title":"Antiandrogenic therapy with ciproterone acetate in female patients who suffer from both androgenetic alopecia and acne vulgaris","volume":"87","author":"Coneac","year":"2014","journal-title":"Clujul Med"},{"key":"2026091106564491600_bib101","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3109\/00016349009021041","article-title":"Ovulation inhibitors containing cyproterone acetate or desogestrel in the treatment of hyperandrogenic symptoms","volume":"69","author":"Erkkola","year":"1990","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2026091106564491600_bib102","first-page":"E64","article-title":"A systematic review and meta-analysis of randomized controlled trials of United States Food and Drug Administration-approved, home-use, low-level light\/laser therapy devices for pattern hair loss: device design and technology","volume":"14","author":"Lueangarun","year":"2021","journal-title":"J Clin Aesthet Dermatol"},{"key":"2026091106564491600_bib103","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/jocd.12983","article-title":"Excellent response to mesotherapy as adjunctive treatment in male androgenetic alopecia","volume":"19","author":"Melo","year":"2020","journal-title":"J Cosmet Dermatol"},{"key":"2026091106564491600_bib104","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.jaad.2020.06.1021","article-title":"The effect of platelet-rich plasma on female androgenetic alopecia: a randomized controlled trial","volume":"83","author":"Dubin","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"2026091106564491600_bib105","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3390\/jpm12030342","article-title":"Effectiveness of platelet-rich plasma therapy in androgenic alopecia-A meta-analysis","volume":"12","author":"Georgescu","year":"2022","journal-title":"J Pers Med"},{"key":"2026091106564491600_bib106","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijwd.2018.08.004","article-title":"Platelet-rich plasma for androgenetic alopecia: a review of the literature and proposed treatment protocol","volume":"5","author":"Stevens","year":"2019","journal-title":"Int J Womens Dermatol"},{"key":"2026091106564491600_bib107","doi-asserted-by":"crossref","first-page":"320","DOI":"10.7241\/ourd.20183.25","article-title":"Micronutrients in hair loss","volume":"9","author":"Ruiz-Tagle","year":"2018","journal-title":"Our Dermatol. Online"},{"key":"2026091106564491600_bib108","doi-asserted-by":"crossref","DOI":"10.25259\/CSDM_262_2023","article-title":"Controversies of micronutrients supplementation in hair loss","volume":"4","author":"Nagendran","year":"2024","journal-title":"Cosmoderma"},{"key":"2026091106564491600_bib109","doi-asserted-by":"crossref","first-page":"G43","DOI":"10.1093\/ejendo\/lvad096","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"189","author":"Teede","year":"2023","journal-title":"Eur J Endocrinol"},{"key":"2026091106564491600_bib110","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.5958\/0976-5506.2019.03189.9","article-title":"Relationship between testosterone and body mass index, hirsutism, alopecia, acne, type of menstrual cycle, and levels of interleukin-1\u03b2, interleukin-17, interleukin-27 and interleukin-35 for infertile women with polycystic ovary syndrome","volume":"10","author":"Hantoosh","year":"2019","journal-title":"Indian J Public Health Res Dev"},{"key":"2026091106564491600_bib111","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0222533","article-title":"Genetic variations associated with response to dutasteride in the treatment of male subjects with androgenetic alopecia","volume":"14","author":"Rhie","year":"2019","journal-title":"PLoS One"},{"key":"2026091106564491600_bib112","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4103\/jrms.JRMS_27_19","article-title":"The effect of GGC and CAG repeat polymorphisms on the androgen receptor gene in response to finasteride therapy in men with androgenetic alopecia","volume":"24","author":"Ghassemi","year":"2019","journal-title":"J Res Med Sci"},{"key":"2026091106564491600_bib113","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ad.2014.07.006","article-title":"Histologic features of alopecias\u2013part I: nonscarring alopecias","volume":"106","author":"Bern\u00e1rdez","year":"2015","journal-title":"Actas Dermosifiliogr"},{"key":"2026091106564491600_bib114","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1016\/j.csbj.2024.06.026","article-title":"Application of multi-omics techniques to androgenetic alopecia: current status and perspectives","volume":"23","author":"Li","year":"2024","journal-title":"Comput Struct Biotechnol J"},{"key":"2026091106564491600_bib115","article-title":"Integrative Proteo-Transcriptomic characterization of androgenetic alopecia identifying ME1-mediated PPAR signaling as a potential mediator","volume":"24","author":"Dai","year":"2024","journal-title":"J Cosmet Dermatol"},{"key":"2026091106564491600_bib116","doi-asserted-by":"crossref","first-page":"44","DOI":"10.5021\/ad.23.082","article-title":"The quality of life and psychosocial impact on female pattern hair loss","volume":"36","author":"Hwang","year":"2024","journal-title":"Ann Dermatol"},{"key":"2026091106564491600_bib117","article-title":"Understanding the Association between mental health and hair loss","volume":"17","author":"Malta","year":"2025","journal-title":"Cureus"},{"key":"2026091106564491600_bib118","article-title":"Female pattern hair loss and negative psychological impact: possible role of brain-derived neurotrophic factor (BDNF)","volume":"13","author":"Mohamed","year":"2023","journal-title":"Dermatol Pract Concept"},{"key":"2026091106564491600_bib119","doi-asserted-by":"crossref","DOI":"10.5812\/ijem-159124","article-title":"Uncovering the hidden connections between PCOS and Alzheimer\u2019s disease: a two-sample mendelian randomization perspective","volume":"23","author":"Motafeghi","year":"2025","journal-title":"Int J Endocrinol Metabol"}],"container-title":["Endocrine Connections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ec.bioscientifica.com\/view\/journals\/ec\/15\/5\/EC-25-0728.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ec.bioscientifica.com\/downloadpdf\/journals\/ec\/15\/5\/EC-25-0728.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/ec\/article-pdf\/doi\/10.1530\/EC-25-0728\/504572\/ec-25-0728.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/ec\/article-pdf\/doi\/10.1530\/EC-25-0728\/504572\/ec-25-0728.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T10:57:01Z","timestamp":1789124221000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/ec\/article\/15\/5\/e250728\/75348\/Androgenetic-alopecia-in-polycystic-ovary-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":119,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5,1]]}},"URL":"https:\/\/doi.org\/10.1530\/ec-25-0728","relation":{},"ISSN":["2049-3614"],"issn-type":[{"value":"2049-3614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]},"article-number":"e250728"}}